Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Free Report) have received a consensus recommendation of “Moderate Buy” from the seven analysts that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $19.14.

Several brokerages recently issued reports on SBRA. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Scotiabank increased their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Friday, October 11th. Truist Financial increased their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, Mizuho reissued a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, December 5th.

Read Our Latest Stock Analysis on SBRA

Institutional Trading of Sabra Health Care REIT

A number of hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. boosted its stake in shares of Sabra Health Care REIT by 0.8% in the third quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust’s stock worth $401,479,000 after buying an additional 167,069 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Sabra Health Care REIT by 1.7% in the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock worth $117,165,000 after buying an additional 104,533 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Sabra Health Care REIT by 8.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust’s stock worth $87,502,000 after buying an additional 365,855 shares during the last quarter. LSV Asset Management boosted its stake in shares of Sabra Health Care REIT by 2.5% in the second quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust’s stock worth $67,465,000 after buying an additional 104,800 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Sabra Health Care REIT by 3.8% in the second quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust’s stock worth $52,275,000 after buying an additional 124,825 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Trading Up 0.7 %

SBRA opened at $17.50 on Friday. The firm has a market cap of $4.14 billion, a price-to-earnings ratio of 42.68, a PEG ratio of 2.22 and a beta of 1.24. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a 12 month low of $12.83 and a 12 month high of $20.03. The stock has a fifty day moving average price of $18.52 and a 200-day moving average price of $17.07.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last announced its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The business had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. During the same period in the prior year, the company earned $0.34 earnings per share. As a group, equities research analysts anticipate that Sabra Health Care REIT will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.86%. Sabra Health Care REIT’s payout ratio is 292.69%.

Sabra Health Care REIT Company Profile

(Get Free Report

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Recommended Stories

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.